De Laere Pharma
The computed 12-month bankruptcy probability of De Laere Pharma is 1.9% (moderate). The 2024 annual accounts show equity of €26k and a net result of €13k. Equity is growing by ~24.7% per year across the filed fiscal years. Its solvency ranks better than 83% of 6698 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €26k |
| Net result | €13k |
| Better than sector | 83% |
| Active | 5 yrs |
Exceptional profile, strong across almost every axis.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 61.7% | 20.4% | |
| Net result | €13k | €4k | |
| Equity | €26k | €16k | |
| Gross operating margin | €19k | €24k | |
| Total assets | €43k | €94k |
| Fiscal year | 2024 |
|---|---|
| Deposit | micro |
| Revenue | - |
| EBITDA | €18k |
| Net profit | €13k |
| Cash flow | €14k |
| Staff costs | - |
| Income taxes | €4k |
| Dividends | €35k |
| Total assets | €43k |
| Equity | €26k |
| Debt | €16k |
| of which ≤ 1y | €16k |
| of which > 1y | - |
| Working capital | €23k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 2.41 |
| Quick ratio | 2.41 |
| Working capital ratio | 54.2% |
| Solvency | 61.7% |
| Debt / equity | 0.62 |
| Long-term debt ratio | - |
| Interest coverage | 25.81 |
| Gross margin | - |
| Net margin | - |
| ROA | 31.2% |
| ROE | 50.6% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €43k |
| Fixed assets | 21/28 | €3k |
| Tangible fixed assets | 22/27 | €3k |
| Financial fixed assets | 28 | €300 |
| Current assets | 29/58 | €39k |
| Amounts receivable within one year | 40/41 | €21k |
| Investments | 50/53 | €9k |
| Cash & bank | 54/58 | €8k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €43k |
| Equity | 10/15 | €26k |
| Contributions / capital | 10/11 | €3k |
| Reserves | 13 | €24k |
| Accumulated profits (losses) | 14 | €293 |
| Amounts payable | 17/49 | €16k |
| Amounts payable within one year | 42/48 | €16k |
| Trade debts payable within one year | 44 | €599 |
| Income statement | ||
| Gross operating margin | 9900 | €19k |
| Operating result | 9901 | €18k |
| Financial income | 75 | €31 |
| Financial charges | 65 | €714 |
| Result before taxes | 9903 | €17k |
| Income taxes | 67/77 | €4k |
| Net result for the period | 9904 | €13k |
| Result to be appropriated | 9905 | €13k |
-
Goedele VANDAMMEDirectorState Gazette act 22093812 (04-08-2022)Current01-08-2022 → present
| NACE primary | Detailhandel in farmaceutische producten(47730) |
| Legal form | Private limited company(610) |
| Incorporation | 12-02-2021 |
| Status | Active |
| Postal code | 8670 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 38018A0798/00A000 | Flanders | 445 m² | 1 · 106 m² | 7.5 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
26-06-2024 Registered office moved from Koksijde to Oostduinkerke
- Zeelaan 95 bus 203, 8670 Koksijde → Nieuwe Ydelaan 38, 8670 Oostduinkerke
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "Nieuwe Ydelaan 38, 8670 Oostduinkerke",
"city": "Oostduinkerke",
"region": "vlaams_gewest",
"street": "Nieuwe Ydelaan",
"country": "BE",
"postcode": "8670",
"box_number": null,
"street_number": "38",
"locality_suffix": null
},
"old_address": {
"raw": "Zeelaan 95 bus 203, 8670 Koksijde",
"city": "Koksijde",
"region": "vlaams_gewest",
"street": "Zeelaan",
"country": "BE",
"postcode": "8670",
"box_number": "203",
"street_number": "95",
"locality_suffix": null
},
"effective_date": "2024-04-26",
"evidence_quote": "Het bestuursorgaan beslist om de zetel van de vennootschap te verplaatsen van Zeelaan 95 bus 203. 8670 Koksijde naar Nieuwe Ydelaan 38, 8670 Oostduinkerke met ingang vanaf 26 april 2024.",
"region_changed": false,
"is_statute_change": true,
"nationality_change": false,
"old_address_source": "header_volledig_adres",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "absolute",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-06-26",
"filing_date": "2024-06-18",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "raad_van_bestuur",
"date": "2024-05-28",
"unanimous": null
},
"subject_company": {
"kbo": "0763.546.683",
"name_full": "DE LAERE PHARMA",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "org",
"org_kbo": "0470.882.243",
"org_name": "D\u0026P Diksmuide BV",
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": []
}04-08-2022 Goedele VANDAMME appointed as director
- Goedele VANDAMME, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Goedele VANDAMME",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": "niet_statutair",
"compensated": false,
"effective_date": "2022-08-01",
"evidence_quote": "De benoeming van mevrouw Goedele VANDAMME als niet-statutaire bestuurder van de vennotoschap met ingang van 1 augustus 2022 en voor onbepaalde duur.",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2022-08-04",
"filing_date": "2022-07-27",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "bijzondere_algemene_vergadering",
"date": "2022-07-15",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0763.546.683",
"name_full": "De Laere Pharma",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Thijs DE LAERE",
"org_rep_person_name": null,
"person_role_at_subject": "Bestuurder"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | De Laere Pharma |